Analysis of lymphocyte subgroups in Crimean-Congo hemorrhagic fever

International Journal of Infectious Diseases

Volumn 13, Issue 5, 2009, Pages 560-563

  Akinci, Esragül ^a   Yilmaz, Mesude ^a   Bodur, Hürrem ^a   Öngürü, Pinar ^a   Bayazit, Fatma Nurhayat ^a   Erbay, Ayşe ^a   Özet, Gülsüm ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Crimean Congo hemorrhagic fever; Lymphocyte subgroups; T lymphocytes

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY; VIRUS RNA;

ADOLESCENT; ADULT; ARTICLE; CD3+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL TRIAL; CONTROLLED STUDY; CYTOTOXICITY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FATALITY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; PATHOGENESIS; PERIPHERAL CIRCULATION; POLYMERASE CHAIN REACTION; SPRING; SUMMER; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; VIRUS DETECTION; VIRUS HEMORRHAGIC FEVER; VIRUS LOAD;

ADOLESCENT; ADULT; ANTIGENS, CD3; CD8-POSITIVE T-LYMPHOCYTES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEMORRHAGIC FEVER VIRUS, CRIMEAN-CONGO; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; IMMUNOGLOBULIN M; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; RNA, VIRAL; TURKEY; VIRAL LOAD; YOUNG ADULT;

EID: 68949186168     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2008.08.027     Document Type: Article

References (19)

1. Whitehouse C.A. Crimean-Congo hemorrhagic fever. Antiviral Res 64 (2004) 145-160
2. Burt F.J., Leman P.A., Smith J.F., and Swanepoel R. The use of a reverse transcription-polymerase chain reaction for the detection of viral nucleic acid in the diagnosis of Crimean-Congo haemorrhagic fever. J Virol Methods 70 (1998) 129-137
3. Centers for Disease Control and Prevention (CDC). Viral hemorrhagic fever: initial management of suspected and confirmed cases. MMWR Morb Mortal Wkly Rep 1983;32:27S-38S.
4. Charrel R.N., Attoui H., Butenko A.M., Clegg J.C., Deubel V., Frolova T.V., et al. Tick-borne virus diseases of human interest in Europe. Clin Microbiol Infect 10 (2004) 1040-1055
5. Andersson I., Bladh L., Mousavi-Jazi M., Magnusson K.E., Lundkvist A., Haller O., et al. Human MxA protein inhibits the replication of Crimean-Congo hemorrhagic fever virus. J Virol 78 (2004) 4323-4329
6. Ergönül O., Celikbaş A., Dokuzoguz B., Eren S., Baykam N., and Esener H. Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy. Clin Infect Dis 39 (2004) 284-287
7. Karti S.S., Odabasi Z., Korten V., Yilmaz M., Sonmez M., Caylan R., et al. Crimean-Congo hemorrhagic fever in Turkey. Emerg Infect Dis 10 (2004) 1379-1384
8. Bakir M., Ugurlu M., Dokuzoguz B., Bodur H., Tasyaran M.A., Vahaboglu H., and Turkish CCHF Study Group. Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measures. J Med Microbiol 54 (2005) 385-389
9. Ozkurt Z., Kiki I., Erol S., Erdem F., Yilmaz N., Parlak M., et al. Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy. J Infect 52 (2006) 207-215
10. Cevik M.A., Erbay A., Bodur H., Gülderen E., Baştuǧ A., Kubar A., et al. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality. Int J Infect Dis 12 (2008) 374-379
11. Cevik M.A., Erbay A., Bodur H., Eren S.S., Akinci E., Sener K., et al. Viral load as a predictor of outcome in Crimean-Congo hemorrhagic fever. Clin Infect Dis 45 (2007) e96-100
12. Yapar M., Aydogan H., Pahsa A., Besirbellioglu B.A., Bodur H., Basustaoglu A.C., et al. Rapid and quantitative detection of Crimean-Congo hemorrhagic fever virus by one-step real-time reverse transcriptase-PCR. Jpn J Infect Dis 58 (2005) 358-362
13. Azeredo E.L., Zagne S.M., Alvarenga A.R., Nogueira R.M., Kubelka C.F., and de Oliveira-Pinto L.M. Activated peripheral lymphocytes with increased expression of cell adhesion molecules and cytotoxic markers are associated with dengue fever disease. Mem Inst Oswaldo Cruz 101 (2006) 437-449
14. Papa A., Bino S., Velo E., Harxhi A., Kota M., and Antoniadis A. Cytokine levels in Crimean-Congo hemorrhagic fever. J Clin Virol 36 (2006) 272-276
15. Ergonul O., Tuncbilek S., Baykam N., Celikbas A., and Dokuzoguz B. Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever. J Infect Dis 193 (2006) 941-944
16. Onguru P., Akgul E.O., Akinci E., Yaman H., Kurt Y.G., Erbay A., et al. High serum levels of neopterin in patients with Crimean-Congo hemorrhagic fever and its relation with mortality. J Infect 56 (2008) 366-370
17. Yilmaz M., Aydin K., Akdogan E., Sucu N., Sonmez M., Omay S.B., et al. Peripheral blood natural killer cells in Crimean-Congo hemorrhagic fever. J Clin Virol 42 (2008) 415-417
18. Bradfute S.B., Warfield K.L., and Bavari S. Functional CD8+ T cell responses in lethal Ebola virus infection. J Immunol 180 (2008) 4058-4066
19. Lei H.Y., Yeh T.M., Liu H.S., Lin Y.S., Chen S.H., and Liu C.C. Immunopathogenesis of dengue virus infection. J Biomed Sci 8 (2001) 377-388